MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin

Yihui Wen, Hua Li, Yan Zeng, Weiping Wen, Kelsey P. Pendleton, Vivian W.Y. Lui, Ann Marie Egloff, Jennifer R. Grandis

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin'. Together they form a unique fingerprint.

Medicine & Life Sciences